Literature DB >> 2460119

Human interferons inhibit experimental metastases of a human melanoma cell line in nude mice.

P Ramani1, F R Balkwill.   

Abstract

Therapy with human lymphoblastoid interferon HuIFN-alpha(N1), or recombinant human interferon gamma, rHuIFN-gamma, inhibited experimental pulmonary metastases of the human melanoma cell line, DX3-azac, in BALB/c nude mice and significantly prolonged survival. The human IFNs had no effect on nude mouse lung and spleen NK cell activity, lung macrophage activity, haemoglobin or white cell counts. HuIFN-alpha(N1) had no effect on the levels of the IFN induced enzyme 2-5A synthetase in nude mouse lungs although the rHuIFN-gamma caused some elevation. In addition, clearance of radiolabelled DX3-azac cells was identical in control or human IFN treated mice, and there was no histological evidence of an increase in immune effector cells associated with the metastatic lesions in treated mice. Human IFN therapy did not affect the state of differentiation of the melanoma cells in vivo as measured by melanin content, but both IFNs inhibited the development of colonies of DX3-azac cells in vitro. We conclude that in this model system IFNs have direct anti-proliferative effects on metastatic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460119      PMCID: PMC2246603          DOI: 10.1038/bjc.1988.217

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Interferons and the regulation of oncogenes.

Authors:  G J Jonak; E Knight
Journal:  Interferon       Date:  1986

2.  Effects of mouse interferon on human tumour xenografts in the nude mouse host.

Authors:  F R Balkwill; E Proietti
Journal:  Int J Cancer       Date:  1986-09-15       Impact factor: 7.396

Review 3.  Antitumor effects of interferon.

Authors:  I Gresser; M G Tovey
Journal:  Biochim Biophys Acta       Date:  1978-10-27

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Differential action of six human interferons against two human carcinomas growing in nude mice.

Authors:  F R Balkwill; L Goldstein; N Stebbing
Journal:  Int J Cancer       Date:  1985-05-15       Impact factor: 7.396

6.  Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine.

Authors:  E J Ormerod; C A Everett; I R Hart
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

7.  rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.

Authors:  R H Silverman; J J Skehel; T C James; D H Wreschner; I M Kerr
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  Antitumor and antimetastatic activities of human recombinant interferon alpha A/D.

Authors:  J Nishimura; K Mitsui; T Ishikawa; Y Tanaka; R Yamamoto; Y Suhara; H Ishitsuka
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

9.  The effect of interferon on experimental metastases in immunocompetent and immunodeficient mice.

Authors:  P Ramani; I R Hart; F R Balkwill
Journal:  Int J Cancer       Date:  1986-04-15       Impact factor: 7.396

10.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs.

Authors:  D A Hume; A P Robinson; G G MacPherson; S Gordon
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  4 in total

1.  Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Authors:  Julianne L Holleran; Carson J Miller; Nancy L Edgehouse; Theresa P Pretlow; Lloyd A Culp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 2.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

3.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991

4.  Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.

Authors:  D S Hoon; Y Hayashi; T Morisaki; L J Foshag; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.